ORMP vs RARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ORMP

32.1
AI Score
VS
RARE Wins

RARE

52.5
AI Score

Investment Advisor Scores

ORMP

32score
Recommendation
SELL

RARE

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ORMP RARE Winner
Revenue 2.00M 350.00M RARE
Net Income -7.64M -277.00M ORMP
Net Margin -382.1% -79.1% RARE
Operating Income -4.50M -244.00M ORMP
ROE -5.4% 95.2% RARE
ROA -5.2% -21.9% ORMP
Total Assets 147.54M 1.26B RARE
Current Ratio 23.94 1.73 ORMP
Free Cash Flow -3.52M -296.00M ORMP

Relative Price Performance (Last 90 Days)

ORMP 1M: -11.4% · 3M: -1.8% RARE 1M: -42.6% · 3M: -54.8%

Current Technical Phase

ORMP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.5 · Price: $4.49

RARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -24.3%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $15.22

Fundamentals Snapshot

Metric ORMP RARE
Market Cap — —
Forward P/E 0.0 22.5
Trailing P/E 1.1 —
Revenue (TTM) — —
Revenue Growth -1.0% 0.3%
Gross Margin — -0.2%
Operating Margin 0.0% -0.4%
EPS 4.13 -5.72
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, RARE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.